Quantcast

Posts related to ‘OGXI’

OncoGenex Prices Secondary Offering, Shares Fall (OGXI)

Posted: March 16, 2012 at 12:47 pm

Cancer therapy developer OncoGenex Pharmaceuticals Inc. (NASDAQ: OGXI) has priced a secondary offering of 4.165 million common shares at $12.00/share, a discount of 31% to yesterday’s closing price of $17.43. ...
Read Full Story »

Top Active Trader Alert Stocks (ABK, AAPL, ARMH, CTIC, CWTR, INFN, MSFT, OGXI)

Posted: October 19, 2010 at 8:55 am

Active traders and day traders have many stocks to choose from this Wednesday morning.  We are tracking news and moves in shares of Some of the most active stocks or ...
Read Full Story »

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Posted: May 27, 2009 at 1:34 pm

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend.   This is broken down ...
Read Full Story »

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Posted: May 14, 2009 at 4:56 pm

We are just about to get the first round of abstracts from companies presenting data at this year's American Society of Clinical Oncology meeting for 2009.  At BioHealthInvestor.com we compiled ...
Read Full Story »